| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-106 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-106 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-107 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-125a | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-125b | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-126 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-128a | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-130a | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-130b | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-137 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-182 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-197 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-199a | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-155 | Paclitaxel | breast cancer | Resistant | Low | 20371610 | |
| miR-148a | Paclitaxel | prostate cancer | Sensitive | Low | 20406806 | |
| miR-100 | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-100 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-106b | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-106b | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-125b | Paclitaxel | breast cancer | Resistant | Low | 20460378 | |
| miR-140 | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-140 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-146a | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-146a | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-146b | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-146b | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-15b | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-15b | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-16 | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-16 | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-17 | Paclitaxel | breast cancer | Sensitive | High | 20460378 | |
| miR-17 | Paclitaxel | breast cancer | Resistant | High | 20460378 | |
| miR-135a | Paclitaxel | non-small cell lung carcinoma | Resistant | Low | 21552288 | |
| miR-19 | Paclitaxel | breast cancer | Resistant | Low | 21853360 | |
| miR-130b | Paclitaxel | ovarian cancer | Sensitive | Low | 22005523 | |
| miR-199a | Paclitaxel | ovarian cancer | Sensitive | Low | 22498306 | |
| miR-1 | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-10a | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-10b | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-125b | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-126 | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-138 | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-144 | Paclitaxel | prostate cancer | Sensitive | Low | 22768203 | |
| miR-146a | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-155 | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-17 | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-18a | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-193b | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-137 | Paclitaxel | breast cancer | Sensitive | Low | 23178914 | |
| miR-125b | Paclitaxel | breast cancer | Resistant | Low | 23255607 | |
| miR-125a | Paclitaxel | colon cancer | Sensitive | Low | 23327190 | |
| miR-125b | Paclitaxel | colon cancer | Sensitive | Low | 23327190 | |
| miR-155 | Paclitaxel | ovarian cancer | Sensitive | High | 23627607 | |
| miR-106b* | Paclitaxel | ovarian cancer | Sensitive | High | 23697367 | |
| miR-19a | Paclitaxel | ovarian cancer | Resistant | High | 23697367 | |
| miR-106a | Paclitaxel | ovarian cancer | Resistant | Low | 23807165 | |
| miR-1197 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1200 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-124* | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1250 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1264 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1265 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1268 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1277 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-1291 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-130a | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-130b* | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-140 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-15a | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-188 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-193b* | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-195 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-199a | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-146a | Paclitaxel | tumorigenic mammary stem cell | Sensitive | Low | 23977446 | |
| miR-103-2* | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-106b | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-10a | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-10b | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-1204 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-125a | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-126 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-127 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-128 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-129 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-1296 | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-130b* | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| miR-130b* | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-132 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-133a | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-133a | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-133b | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-134 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-139 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-141 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-143 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-143* | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-145* | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-155* | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-182 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-187 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-18a* | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-1908 | Paclitaxel | lung cancer | Resistant | High | 24157646 | |
| miR-106a | Paclitaxel | lung cancer | Sensitive | High | 24220856 | |
| miR-106a | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-125a | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| miR-126 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-130a | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| miR-130b | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-134 | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| miR-141 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-142 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-148a | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| miR-17 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-192 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-193b | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| miR-195 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-19b | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-145 | Paclitaxel | ovarian cancer | Sensitive | Low | 24510775 | |
| miR-107 | Paclitaxel | ovarian cancer | Sensitive | High | 24591819 | |
| miR-187 | Paclitaxel | ovarian cancer | Sensitive | High | 24591819 | |
| miR-195 | Paclitaxel | ovarian cancer | Sensitive | High | 24591819 | |
| miR-101 | Paclitaxel | lung adenocarcinoma | Sensitive | High | 24755562 | |
| miR-106a | Paclitaxel | lung adenocarcinoma | Sensitive | High | 24755562 | |
| miR-1246 | Paclitaxel | lung adenocarcinoma | Resistant | High | 24755562 | |
| miR-1275 | Paclitaxel | lung adenocarcinoma | Resistant | High | 24755562 | |
| miR-1290 | Paclitaxel | lung adenocarcinoma | Resistant | High | 24755562 | |
| miR-16 | Paclitaxel | lung adenocarcinoma | Sensitive | High | 24755562 | |
| miR-17 | Paclitaxel | lung cancer | Sensitive | Low | 24755562 | |
| miR-1973 | Paclitaxel | lung adenocarcinoma | Resistant | High | 24755562 | |
| miR-19a | Paclitaxel | lung adenocarcinoma | Sensitive | High | 24755562 | |
| miR-1287 | Paclitaxel | gastric cancer | Resistant | High | 24817940 | |
| miR-130a | Paclitaxel | gastric cancer | Sensitive | High | 24817940 | |
| miR-181a-2* | Paclitaxel | gastric cancer | Sensitive | High | 24817940 | |
| miR-193b* | Paclitaxel | gastric cancer | Sensitive | High | 24817940 | |
| miR-146a | Paclitaxel | epithelial ovarian cancer | Associated | Low | 24977712 | |
| miR-1290 | Paclitaxel | breast cancer | Resistant | High | 25137071 | |
| miR-194 | Paclitaxel | breast cancer | Sensitive | High | 25137071 | |
| miR-19a | Paclitaxel | breast cancer | Resistant | High | 25137071 | |
| miR-130b | Paclitaxel | ovarian cancer | Resistant | Low | 25155039 | |
| miR-149 | Paclitaxel | breast cancer | Sensitive | Low | 25156775 | |
| miR-193a | Paclitaxel | bladder cancer | Resistant | Low | 25188512 | |
| miR-133a | Paclitaxel | esophageal squamous cell carcinoma | Resistant | Low | 25280517 | |
| miR-133b | Paclitaxel | esophageal squamous cell carcinoma | Resistant | Low | 25280517 | |
| miR-193a | Paclitaxel | bladder cancer | Resistant | Low | 25311867 | |
| miR-100 | Paclitaxel | nasopharyngeal carcinoma | Sensitive | High | 25400759 | |
| miR-1204 | Paclitaxel | nasopharyngeal carcinoma | Sensitive | High | 25400759 | |
| miR-16 | Paclitaxel | lung cancer | Sensitive | Low | 25435430 | |
| miR-193a | Paclitaxel | bladder cancer | Resistant | Low | 25444900 | |
| miR-193a | Paclitaxel | bladder cancer | Resistant | Low | 25542424 | |
| miR-100 | Paclitaxel | nasopharyngeal carcinoma | Sensitive | High | 25756509 | |
| miR-1204 | Paclitaxel | nasopharyngeal carcinoma | Sensitive | Low | 25756509 | |
| miR-197 | Paclitaxel | ovarian cancer | Resistant | Low | 25833695 | |
| miR-130a | Paclitaxel | prostate cancer | Sensitive | Low | 26074357 | |
| miR-149 | Paclitaxel | ovarian cancer | Sensitive | Low | 26223974 | |
| miR-128 | Paclitaxel | lung adenocarcinoma | Sensitive | High | 26323677 | |
| miR-135b | Paclitaxel | lung adenocarcinoma | Resistant | High | 26323677 | |
| miR-155 | Paclitaxel | lung adenocarcinoma | Resistant | High | 26323677 | |
| miR-181a | Paclitaxel | lung adenocarcinoma | Associated | Low | 26323677 | |
| miR-181b | Paclitaxel | lung adenocarcinoma | Resistant | High | 26323677 | |
| miR-181c | Paclitaxel | lung adenocarcinoma | Resistant | High | 26323677 | |
| miR-191 | Paclitaxel | lung adenocarcinoma | Sensitive | High | 26323677 | |
| miR-19a | Paclitaxel | lung adenocarcinoma | Resistant | High | 26323677 | |
| miR-125b | Paclitaxel | lung cancer | Sensitive | Low | 26351908 | |
| miR-133b | Paclitaxel | ovarian carcinoma | Sensitive | Low | 26396496 | |
| miR-17 | Paclitaxel | ovarian carcinoma | Resistant | Low | 26500892 | |
| miR-106b-25 | Paclitaxel | breast cancer | Resistant | Low | 26573761 | |
| miR-143 | Paclitaxel | colorectal cancer | Sensitive | Low | 26581910 |